Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

NCT02177695

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Completed

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

NCT00981656

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Emory Crawford Long Hospital Atlanta, Georgia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • St. Agnes Hospital Cancer Center Baltimore, Maryland, United States
  • Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

MK-3475/BCG in High Risk Superficial Bladder Cancer

NCT02324582

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Simmons Cancer Institute-SIU School of Medicine Springfield, Illinois, United States
  • Southern Illinois University School of Medicine Springfield, Illinois, United States
  • Henry Ford Health Systems Detroit, Michigan, United States
View Trial Details
Completed

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

NCT02091141

Conditions
Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +16 more
Locations
  • Western Regional Medical Center at Cancer Treatment Centers of America Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Science 37, Inc Culver City, California, United States
View all 60 locations
View Trial Details
Completed

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

NCT04209114

Conditions
Bladder Cancer, Bladder Tumor, Female Urogenital Diseases, +11 more
Locations
  • Local Institution - 0080 Gilbert, Arizona, United States
  • Local Institution - 0136 Tucson, Arizona, United States
  • Local Institution - 0029 La Jolla, California, United States
  • Local Institution - 0015 Orange, California, United States
View all 116 locations
View Trial Details
Completed

Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing

NCT03558087

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Univerity of Southern California Los Angeles, California, United States
  • Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details

Related conditions